ASSAY RECORD
Results
Showing up to 20 records.
| NO. | RECORD ID | NAME | SEQUENCE | SOURCE ORGANISM | FUNCTION CATEGORY | TARGET ORGANISM | ACTIVITY | ASSAY METHOD | PMID | PATENT NO | VERIFICATION STATUS |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 420261 | Rec_0432919 | Unnamed |
GLLRRFRKKIGKKLKKITR |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial |
Escherichia coli TOP10 (suicide-expression host) |
100 % | suicide-expression growth inhibition; 0.1% arabinose |
- | US 2008/0213430 A1 |
YES |
| 420262 | Rec_0432920 | AGQTLTASGD |
AGQTLTASGD |
synthetic construct [Synthetic] |
Tumor homing, Targeting, Protein-binding |
NG2Δ3 proteoglycan |
- | phage-display biopanning on immobilized NG2Δ3 |
10383148 | US 6528481 B1 |
YES |
| 420263 | Rec_0432921 | ISELGW |
ISELGW |
Homo sapiens [Animal] |
Antioxidant, Radical scavenging |
peroxyl radicals |
4479 μM Trolox equivalents/mmol | ORAC |
- | - |
YES |
| 420264 | Rec_0432922 | Bac221 |
RCARIVVIRVAR |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial |
Pseudomonas aeruginosa H1001 |
- | lux-based antibacterial killing assay |
- | US 2008/0207522 A1 |
YES |
| 420265 | Rec_0432923 | Ctri9594 |
GVVDTLKNLLMGLL |
Chaerilus tricostatus [Animal] |
Antimicrobial |
Escherichia coli AB94012 |
>100 μg/mL | MIC |
34438946 | - |
YES |
| 420266 | Rec_0432924 | Ctri9594 |
GVVDTLKNLLMGLL |
Chaerilus tricostatus [Animal] |
Antimicrobial |
Pseudomonas aeruginosa AB93066 |
>100 μg/mL | MIC |
34438946 | - |
YES |
| 420267 | Rec_0432925 | Ctri9594 |
GVVDTLKNLLMGLL |
Chaerilus tricostatus [Animal] |
Antimicrobial |
Candida albicans AY93025 |
>100 μg/mL | MIC |
34438946 | - |
YES |
| 420268 | Rec_0432926 | NZ17125 |
GFCWRVCASRNGLRVCYRRCN |
synthetic construct [Synthetic] |
Cytotoxic |
HepG2 human hepatocellular carcinoma cells |
299 μg/mL | CC50 |
32576824 | - |
YES |
| 420269 | Rec_0432927 | NZ17125 |
GFCWRVCASRNGLRVCYRRCN |
synthetic construct [Synthetic] |
Cytotoxic |
HK-2 human kidney proximal tubule cells |
110 μg/mL | CC50 |
32576824 | - |
YES |
| 420270 | Rec_0432928 | Ostrich AvBD7 |
FPRLDNSCFIQNGRCFPGICRRPYYWIGTCSNGYSCCRK |
Struthio camelus [Animal] |
Antimicrobial, Antibacterial |
Gram-positive and Gram-negative bacteria |
- | qualitative antibacterial activity assay |
25127671 | - |
YES |
| 420271 | Rec_0432929 | Leumorphin |
YGGFLRRQFKVVTRSQEDPNAYYEELFDV |
Sus scrofa [Animal] |
Opioid, Kappa-opioid receptor agonist, Receptor modulation |
human kappa opioid receptor (hKOR) |
21 nM | EC50 (receptor activation assay) |
25937170 | - |
YES |
| 420272 | Rec_0432930 | EDELQDKIHPF (E-11-F) |
EDELQDKIHPF |
Bos taurus [Animal] |
Antioxidant, Reactive oxygen species inhibition |
Caco-2 cells |
- | intracellular ROS inhibition assay |
32013158 | - |
YES |
| 420273 | Rec_0432931 | Brevinin-1Pk |
FLPIIAGVAAKVFPKIFCTISKKC |
Rana pipiens [Animal] |
Antimicrobial, Antibacterial |
Staphylococcus aureus |
2 μM | growth inhibition assay |
- | - |
YES |
| 420274 | Rec_0432932 | Brevinin-1Pk |
FLPIIAGVAAKVFPKIFCTISKKC |
Rana pipiens [Animal] |
Antimicrobial, Antibacterial |
Escherichia coli |
16 μM | growth inhibition assay |
- | - |
YES |
| 420275 | Rec_0432933 | Brevinin-1Pk |
FLPIIAGVAAKVFPKIFCTISKKC |
Rana pipiens [Animal] |
Antimicrobial, Antifungal |
Candida albicans |
32 μM | growth inhibition assay |
- | - |
YES |
| 420276 | Rec_0432934 | VIR-170 |
LEAIPMSIPPEVFFGKPFVF |
synthetic construct [Synthetic] |
Antiviral, HIV infection inhibitor |
HIV-1 NL4-3 |
1520 nM | IC50; HIV-1 infection inhibition assay |
- | US 7,655,629 B2 |
YES |
| 420277 | Rec_0432935 | VIR-170 |
LEAIPMSIPPEVFFGKPFVF |
synthetic construct [Synthetic] |
Antiviral, HIV infection inhibitor |
HIV-1 NL4-3 DTV |
2000 nM | IC50; HIV-1 infection inhibition assay |
- | US 7,655,629 B2 |
YES |
| 420278 | Rec_0432936 | B4 epitope peptide |
FASFDVPSKQPTIDIDLTDI |
Fasciola hepatica [Animal]; synthetic construct [Synthetic] |
B-cell epitope, Immune-response tested |
BALB/c mice |
- | peptide immunization; ELISA/cytokine/T-cell immune-response assays |
25122166 | - |
YES |
| 420279 | Rec_0432937 | ZnT8 p8 (27-41) |
LQQKPVNKDQCPRER |
Homo sapiens [Animal]; synthetic construct [Synthetic] |
CD4 T-cell epitope, Immunogenic, Type 1 diabetes-related |
human peripheral blood CD4+ T cells |
- | PBMC peptide stimulation; cytokine secretion and CD4+ T-cell proliferation assay |
23390544 | - |
YES |
| 420280 | Rec_0432938 | TroHepc2-22 |
GIKCRFCCGCCIPRVCGLCCRF |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial |
Streptococcus agalactiae LFY-5 |
32 μM | MBC |
37298202 | - |
YES |